.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Prof. Dr. Thilo Hackert

Hamburg / DE

Universitätsklinikum Hamburg-Eppendorf / UKE

Speaker

Fr, 16/02
14:55 – 15:15 0 Min. 20 Min.
Oral presentation
Panel/ General Discussion

Further involvements

Th, 15/02
14:50 – 15:00 8 Min. 2 Min.
Oral presentation
O08
Increased complications and decreased survival after endoscopic bile duct stenting: Time to change the management of Jaundice in resectable pancreatic cancer
Pancreatic cancer
Fr, 16/02
08:50 – 09:00 8 Min. 2 Min.
Oral presentation
O20
Preoperative patient counseling preferences before Pancreatectomy (4PC Studie)
Pancreatic surgery / Robotics
Fr, 16/02
09:20 – 09:30 8 Min. 2 Min.
Oral presentation
O23
Postoperative endoscopic balloon dilatation for delayed gastric emptying after pancreatectomy (eBalloon trial)
Pancreatic surgery / Robotics
Fr, 16/02
14:55 – 15:00 3 Min. 2 Min.
ePoster presentation
P31
Pancreatic surgery in children: Complex, safe and effective
Pancreatic surgery / Robotics
Fr, 16/02
15:45 – 15:55 8 Min. 2 Min.
Oral presentation
O29
A response prediction platform for personalized antitumor therapy in pancreatic cancer
Pancreatic cancer
Fr, 16/02
16:15 – 16:25 8 Min. 2 Min.
Oral presentation
O32
Tumor response grading as a potential prognostic marker in neoadjuvant treated pancreatic carcinoma
Pancreatic cancer
Sa, 17/02
08:30 – 08:40 8 Min. 2 Min.
Oral presentation
O44
Application of liquid biopsy in the clinical management of pancreatic cancer patients
Pancreatic cancer
Sa, 17/02
09:10 – 09:20 8 Min. 2 Min.
Oral presentation
O48
Liquid biopsy shows distinctive proteome of long-term recurrence free survival after resection of pancreatic cancer
Pancreatic cancer
Sa, 17/02
10:20 – 10:25 3 Min. 2 Min.
ePoster presentation
P59
PDAC recurrence monitoring with novel imaging FAPI-PET
Pancreatic cancer
Sa, 17/02
12:40 – 12:50 8 Min. 2 Min.
Oral presentation
O54
KRAS & GNAS mutations in cfDNA and circulating epithelial cells in patients with intraductal papillary mucinous neoplasms – an observational pilot-study regarding the risk of progression to pancreatic cancer
Cystic lesions of the pancreas